An overview of topoisomerase I - Targeting agents

Seminars in Hematology

Volumn 35, Issue 3 SUPPL. 4, 1998, Pages 3-12

  Arbuck, S G ^a   Takimoto, C H ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

9 AMINOCAMPTOTHECIN; CAMPTOTHECIN DERIVATIVE; DNA TOPOISOMERASE INHIBITOR; EXATECAN; IRINOTECAN; LURTOTECAN; RUBITECAN; TOPOTECAN; UNCLASSIFIED DRUG;

CANCER CHEMOTHERAPY; COLORECTAL CANCER; DRUG EFFICACY; DRUG MECHANISM; DRUG SAFETY; DRUG STRUCTURE; HUMAN; OVARY CANCER; PRIORITY JOURNAL; REVIEW;

ANTINEOPLASTIC AGENTS; CAMPTOTHECIN; DNA TOPOISOMERASES, TYPE I; DRUG RESISTANCE, NEOPLASM; ENZYME INHIBITORS; HUMANS; NEOPLASMS; TOPOTECAN;

EID: 0031697965     PISSN: 00371963     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (127)